Filter
472
Filtered Results: 472
Text search:
pyrazinamide
Featured
Recommendations
70
New Publications
131
Language
Document type
No document type
319
Guidelines
78
Manuals
26
Studies & Reports
21
Training Material
12
Strategic & Response Plan
7
Fact sheets
7
Situation Updates
2
Countries / Regions
Western and Central Europe
25
India
25
Nepal
14
Eastern Europe
12
Kenya
11
Argentina
11
Senegal
8
Peru
8
Tanzania
8
Bangladesh
8
Ethiopia
8
South Africa
7
Uganda
7
Malawi
6
Germany
6
Paraguay
6
Indonesia
6
Ukraine
5
Bolivia
5
Zambia
5
Colombia
4
Nigeria
4
Philippines
4
Mozambique
4
Cambodia
4
Brazil
4
Russia
4
Namibia
4
El Salvador
3
Lesotho
3
Ghana
3
Rwanda
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
Botswana
3
Ecuador
3
Myanmar / Burma
3
Eswatini/ Swaziland
3
Benin
2
Cameroon
2
Burkina Faso
2
Zimbabwe
2
Haiti
2
Tajikistan
1
Switzerland
1
Gambia
1
Chile
1
Malaysia
1
Asia
1
Venezuela
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Uruguay
1
Romania
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Liberia
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
129
TB
60
Drugs & Medical Equipment
38
Guidelines
34
Studies & Reports
19
Pediatrics
15
Capacity Building
13
Women & Child Health
9
Paediatrics
8
Policies
7
Demograhic Health Surveys DHS
5
Community Health
5
Disease Prevention & Control
5
Bacteriology
4
COVID-19
3
Countries
3
Statistics
3
HIV & STI
3
Clinical Guidelines
2
Communicable Diseases
2
NTDs & Others
2
Communicable Diseases
1
Dental & Eye Care
1
Clinical Training
1
Public Health
1
Under-5 nutrition
1
Child Health
1
Buruli Ulcer
1
Diabetes
1
Dermatology
1
Maternal & Child Health
1
Public Health
1
Vaccine-preventable Diseases
1
Information, Education and Communication (IEC)
1
Quality Control & Assurance
1
Reproductive Health
1
Toolboxes
Drug resistant TB
43
Adults
30
Children
26
Detection & Diagnosis
24
Essential Medicines & Devices Lists
22
Training
18
Prevention & Control
12
Childhood TB
10
General
10
TB/HIV Coinfection
10
Argentina
9
TB & Prisoners
9
Peru
8
Other Countries
8
Research & Access
8
TB
8
Essential Medicines
6
Romania
6
Tuberculosis
6
Germany
6
Clinical Aspects
5
Children & Adolescents
5
IEC Materials
5
Brazil
5
HIV &TB
5
Disease Prevention & Control
5
Nutrition
5
TB & Drug Abuse
4
Moldova
4
Treatment & Prevention
4
Communication & Training
4
South-east Asia Region
4
Kenya
4
Policies & Strategies
3
Vaccines & Immunization
3
Ukraine
3
Laboratory
3
TB & Other Vulnerable Populations
3
Ethiopia
3
Essential List
3
Hospital Readiness/Essential Health Services
3
Colombia
3
El Salvador
3
Falsified & Substandard
3
Malawi
3
Clinical Guidelines
3
Eastern Europe & Central Asia
3
Country specific
2
South Africa
2
Eastern Mediterranean Region
2
Namibia
2
TB
2
Mozambique
2
Country Guidelines
2
Reports
2
Country Specific
2
TB/HIV
2
TB/COVID-19
2
Latin America
2
Ecuador
2
Prices and Patents
2
Model Formulary
2
Pharmacy Practice
2
Policies and guidelines
2
Uganda
2
HIV and coinfection
2
Kazakhstan
2
Western & Central Europe
2
AmR (Region of Americas)
2
Epidemiology
2
Biosafety
1
Azerbaijan
1
Clinical Aspects, Treatment & Prevention
1
Policies & Strategies
1
Clinical Guidelines
1
Pediatrics
1
Opportunistic Infections
1
Prevention Guidelines
1
National Policies
1
Social Worker
1
Eastern Europe
1
HIV
1
Global
1
People who injecting Drugs
1
Rwanda
1
Prophylaxis
1
Vaccination
1
Health & Refugee
1
Georgia
1
Drug resistance
1
Workplace
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Russia
1
DR Congo
1
Clinical Guidelines
1
Country specific documents
1
Essential Medicines & Medical Devices
1
Community Health Workers CHW
1
Advocacy & Communication
1
Chile
1
Rational use of Medicine
1
Health Worker
1
General
1
Botswana
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Ghana
1
Community Worker
1
TB/HIV Global
1
Lesotho
1
Latin America & the Carribean
1
Clinical Guidelines
1
Nigeria
1
Tajikistan
1
Antiretroviral Treatment ART
1
Preparedness & Prevention
1
Case Definitions
1
Prisoners
1
Meningitis & Encephalitis
1
Volunteers
1
SEAR (South-east Asia Region)
1
HIV & AIDS Treatment in Practice
Issue 203
Lea este folleto para informarse sobre la TB y lo que puede hacer
para curarse. Colóquelo a mano para consultarlo y leerlo cuando
tenga preguntas. Siga el tratamiento para curarse de la TB.
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
The Lancet Global Health January 24, 2022
Surveillance Report
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials...
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)...
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
Module appartenant à la série d’évaluations des capacités des services de santé dans le cadre de la pandémie de COVID-19: orientations provisoires, 12 mai 2021. L'outil d'évaluation de la continuité des services de santé essentiels : Facility Assessment Tool peut être utilisé par les pa...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
